Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart…

By A. Hjalmarson, S. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, J. Kjekshus, J. Wikstrand, D. E. Allaf, J. Vítovec, J. Aldershvile and 13 more. 2000

1,378 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/b440a5262ef7ce205f35be5d06adff8c629b2dd8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Douglas P. Zipes
2. M. Shen

Citations in the corpus

• Cardiorenal syndrome. (2008, neutral): “Nonetheless, it is equally important to acknowledge hat clinicians looking after these patients often are faced ith competing therapeutic choices and that, with the xception of MERIT-HF (Metoprolol Controlled-Release andomised Intervention Trial in Heart Failure) (63), large andomized controlled tri”